J. Ruiz-Bañobre

发表

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

J. Casal-Rubio, B. Campos-Balea, D. Pérez Parente, 2020, Journal of clinical medicine.

Long-term Response to Nivolumab and Acute Renal Failure in a Patient with Metastatic Papillary Renal Cell Carcinoma and a PD-L1 Tumor Expression Increased with Sunitinib Therapy: A Case Report

I. Abdulkader, R. López-López, U. Anido, 2016, Front. Oncol..

Predictive Biomarkers in Metastatic Colorectal Cancer: A Systematic Review.

A. Goel, R. Kandimalla, J. Ruiz-Bañobre, 2019, JCO precision oncology.

Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

M. Esteller, R. Sanz-Pamplona, V. Moreno, 2022, Clinical epigenetics.

Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells.

R. López-López, M. Alonso, N. Csaba, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy.

L. Santomé, R. García-Campelo, J. Mosquera-Martínez, 2019, Translational lung cancer research.

Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy

J. Tubío, R. López-López, C. García-Martínez, 2022, Scientific Reports.

Severe de novo pustular psoriasiform immune‐related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma

P. Nagarajan, Toshiyuki Yamamoto, P. Aung, 2021, Journal of cutaneous pathology.

Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome

I. Abdulkader, R. López-López, U. Anido, 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer

M. Gerlinger, T. Lund, K. Fenwick, 2022, bioRxiv.

DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers.

A. Goel, J. Ruiz-Bañobre, A. Goel, 2019, Gastroenterology.

Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy.

A. Goel, J. Ruiz-Bañobre, A. Goel, 2021, Advances in cancer research.

Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study

R. López-López, L. Santomé, O. Fernández-Calvo, 2021, ESMO open.

Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture

P. Campbell, A. Butler, K. Raine, 2021, Nature Communications.

Molecularly targeted therapy in metastatic CRC

R. López-López, J. Ruiz-Bañobre, E. Brozos-Vázquez, 2022, Foundations of Colorectal Cancer.

Noninvasive detection of microsatellite instability in patients with endometrial cancer

C. Moiola, J. Cueva, R. López-López, 2023, International journal of cancer.

Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature.

E. Pérez-Pampín, R. López-López, A. Gómez-Caamaño, 2017, Lung cancer.

Clinical Significance of a MicroRNA Signature for the Identification and Predicting Prognosis in Colorectal Cancers with Mucinous Differentiation.

R. López-López, A. Goel, F. Balaguer, 2020, Carcinogenesis.

Liquid Biopsy Assessment of Molecular Residual Disease in Localized Colorectal Cancer: Is It Ready for Prime Time?

J. Ruiz-Bañobre, A. Goel, 2023, JAMA oncology.

Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database

Aung Ko Win, M. von Knebel Doeberitz, B. Bonanni, 2023, EClinicalMedicine.

Clinical, molecular, and immune correlates of Immunotherapy Response Score in advanced urothelial carcinoma patients under atezolizumab monotherapy: Analysis of the phase 2 IMvigor210 trial

J. Tubío, R. López-López, J. García-González, 2023, medRxiv.

MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles

C. Andersen, M. Esteller, R. López-López, 2023, iScience.

Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia)

I. Abdulkader, J. Cameselle-Teijeiro, L. Santomé, 2016, Oncology letters.

Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial

J. Tubío, R. López-López, J. García-González, 2023, ESMO open.

Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas

R. López-López, M. Abal, L. Muinelo-Romay, 2023, International journal of molecular sciences.

A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma

J. Tubío, J. García-González, J. Ruiz-Bañobre, 2023, medRxiv.

Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer

A. Gómez-Caamaño, J. Ruiz-Bañobre, N. Fernández-Núñez, 2024, Frontiers in oncology.